388 related articles for article (PubMed ID: 23269411)
1. Inflammation during obesity is not all bad: evidence from animal and human studies.
Ye J; McGuinness OP
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E466-77. PubMed ID: 23269411
[TBL] [Abstract][Full Text] [Related]
2. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.
Yasui M; Tamura Y; Minami M; Higuchi S; Fujikawa R; Ikedo T; Nagata M; Arai H; Murayama T; Yokode M
PLoS One; 2015; 10(8):e0136304. PubMed ID: 26308623
[TBL] [Abstract][Full Text] [Related]
3. Fight against fibrosis in adipose tissue remodeling.
Li S; Gao H; Hasegawa Y; Lu X
Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E169-E175. PubMed ID: 34056922
[TBL] [Abstract][Full Text] [Related]
4. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
[TBL] [Abstract][Full Text] [Related]
5. Adipose tissue vascularization: its role in chronic inflammation.
Ye J
Curr Diab Rep; 2011 Jun; 11(3):203-10. PubMed ID: 21327583
[TBL] [Abstract][Full Text] [Related]
6. Regulation of energy balance by inflammation: common theme in physiology and pathology.
Wang H; Ye J
Rev Endocr Metab Disord; 2015 Mar; 16(1):47-54. PubMed ID: 25526866
[TBL] [Abstract][Full Text] [Related]
7. Why do anti-inflammatory therapies fail to improve insulin sensitivity?
Gao ZG; Ye JP
Acta Pharmacol Sin; 2012 Feb; 33(2):182-8. PubMed ID: 22036866
[TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.
Hellmann J; Tang Y; Kosuri M; Bhatnagar A; Spite M
FASEB J; 2011 Jul; 25(7):2399-407. PubMed ID: 21478260
[TBL] [Abstract][Full Text] [Related]
9. SOCS2 modulates adipose tissue inflammation and expansion in mice.
Val CH; de Oliveira MC; Lacerda DR; Barroso A; Batista NV; Menezes-Garcia Z; de Assis DRR; Cramer AT; Brant F; Teixeira MM; Glória Souza D; Ferreira AM; Machado FS
J Nutr Biochem; 2020 Feb; 76():108304. PubMed ID: 31816561
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance.
Elias I; Franckhauser S; Ferré T; Vilà L; Tafuro S; Muñoz S; Roca C; Ramos D; Pujol A; Riu E; Ruberte J; Bosch F
Diabetes; 2012 Jul; 61(7):1801-13. PubMed ID: 22522611
[TBL] [Abstract][Full Text] [Related]
11. Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance.
Kojta I; Chacińska M; Błachnio-Zabielska A
Nutrients; 2020 May; 12(5):. PubMed ID: 32375231
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
Tam CS; Redman LM
Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
[TBL] [Abstract][Full Text] [Related]
13. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance.
Wang X; Yang Z; Xue B; Shi H
Endocrinology; 2011 Mar; 152(3):836-46. PubMed ID: 21239433
[TBL] [Abstract][Full Text] [Related]
14. Obesity, inflammation, and insulin resistance--a mini-review.
Zeyda M; Stulnig TM
Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
[TBL] [Abstract][Full Text] [Related]
15. The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation.
Wensveen FM; Valentić S; Šestan M; Turk Wensveen T; Polić B
Eur J Immunol; 2015 Sep; 45(9):2446-56. PubMed ID: 26220361
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines.
Ruan H; Lodish HF
Curr Opin Lipidol; 2004 Jun; 15(3):297-302. PubMed ID: 15166785
[TBL] [Abstract][Full Text] [Related]
17. Macrophages, inflammation, and insulin resistance.
Olefsky JM; Glass CK
Annu Rev Physiol; 2010; 72():219-46. PubMed ID: 20148674
[TBL] [Abstract][Full Text] [Related]
18. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice.
Han JH; Shin H; Park JY; Rho JG; Son DH; Kim KW; Seong JK; Yoon SH; Kim W
FASEB J; 2019 Mar; 33(3):4314-4326. PubMed ID: 30566396
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
Esser N; Paquot N; Scheen AJ
Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
